RSS

healthcare

Chancellor of the Exchequer, Philip Hammond, presented his Spring Statement to his peers in parliament yesterday (Tuesday 13 March), but despite his jovial ‘Tigger-like’ mood and demeanour, industry and healthcare experts were not so buoyant. more

News

According to Catalyst Corporate Finance, UK service-based pharma businesses involved in ‘smart’ areas of the market are experiencing heightened interest from domestic and international acquirers. more

Analysis

All signs are that the life sciences and healthcare market is ripe for disruption, with ecommerce coming into its own in the sector. Scott Allison, president Life Sciences & Healthcare, DHL, lists five reasons as to why it is happening now. more

Opinion

Here, Maria Yasko, PR manager at phamax, lists five countries with limited access to healthcare, going into detail about how these countries are suffering from healthcare sector problems and how these are getting in the way of patient access. more

Opinion

According to data from Catalyst Corporate Finance, the UK business of Alantra, 2017 has seen M&A and investment activity in the UK Healthcare sector remain high. Here, Justin Crowther (partner) identifies five significant deals of the year more

News

In this online exclusive, Hitesh Dodhia, superintendent pharmacist at PharmacyOutlet.co.uk, looks at what the forthcoming government budget announcement should set out for pharma and healthcare in the current challenging political landscape. more

Opinion

As people search for healthcare information online more frequently and the digital market keeps growing the boundary between offline & online is becoming more blurred for pharma. Jake Holyoak from Mediaworks details the key challenges & opportunities more

Opinion

GSK Consumer Healthcare, one of the world's largest consumer healthcare companies, has today launched a new high-tech ‘consumer sensory lab’. more

News

Science museum

Shutterstock.com

Diagnostics company, Owlstone Medical, has revealed that its breathalyser, ReCIVA, has been selected to be featured in the Tomorrow’s World gallery at the Science Museum in London. more

Technology

During the Next Generation Dx summit 2017 in Washington, DC, Dr Neil Polwart — Novarum DX founder and BBI group head of mobile — will discuss the impact smartphones will have on the healthcare industry in the next few years. more

Opinion

In the third episode of our series, we talk to Richard Limb who is the new head of Quality Assurance at one of the UK’s independent suppliers of both Specials and clinical trial medicines to healthcare professionals, Nova Laboratories. more

Opinion

Dr Marisa Miraldo, associate professor in Health Economics at Imperial College Business School, London, discusses ways to accelerate innovation in healthcare for the benefit of patients, healthcare providers and industry. more

Opinion

Global healthcare company, Novo Nordisk, and digital platform and data analytics company, Glooko, have launched an integrated app to help people manage diabetes called Cornerstones4Care (C4C). more

Technology

A survey, from digital communications platform ISEBOX, has revealed a massive gap in the information provided by drug companies and what journalists require for content creation more

News

Jonathan Gardiner, packaging technologist at CDMO Almac looks at how packaging can become more efficient more

Opinion

A recent report from market analyst group GBI Research has revealed the extent to which organisations in the pharmaceutical and healthcare industry are planning to invest in big data. more

News

Research from marketing agency Five by Five has revealed that social media is considered the most important aspect of marketing when new healthcare products or services are launched. more

News

The Medica and Compamed trade fairs have come to a close after a consistently high visitor intake from specialists from all sectors of the health industry. more

News

The August Faller Group, pharmaceutical and healthcare packaging solution provider, has reported a turnover of €123.4 million (£955.7 million, $138.3 million) in 2015, ahead of plans to digitalise its business. more

News

Bayer and Biontech, a immunotherapy company headquartered in Mainz have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics specifically for animal health applications. more

News